FN1 and diabetic kidney disease: Collectively, these findings position FN1 not only as a promising biomarker but, more importantly, as an exemplar of the pro-fibrotic endgame in DKD and a pan-fibrosis marker, given its involvement in dysregulated ECM remodeling common to many organs.